Baxter (BAX) Misses Q4 EPS by 10c, Beats on Revenue; Offers FY26 EPS Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. SPCX
2. LEVI
3. SBUX
4. NVDA
5. GOOGL
6. AAPL
7. SPY
8. APLD
9. ORCL
10. USO

Go back to Baxter (BAX) Misses Q4 EPS by 10c, Beats on Revenue; Offers FY26 EPS Guidance

Baxter Reports Fourth-Quarter 2025 Results

February 12, 2026 7:15 AM EST

Fourth-quarter sales from continuing operations of $2.97 billion increased 8% on a reported basis and 3% on an operational basis1,2 Fourth-quarter U.S. GAAP3 diluted earnings per share (EPS) (loss) from continuing operations of ($2.01); adjusted diluted EPS from continuing operations of $0.44 Company advances ongoing board of directors refreshment

DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE: BAX), a global medtech leader, today reported results for the fourth quarter of 2025.

While we delivered sales growth across all segments, our fourth-quarter results did not meet our expectations,... More